What Talphera Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 5 |
| Sells | 0 | 0 |
| Total trades | 0 | 23 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 424,374 |
| Disposed | 0 | 41,218 |
| Net activity | +0 | +383,156 |
Common stock only — 1 reported trade in the last 12 months is in a security these totals do not cover.
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Hoffman Stephen J | Director | Jun 22 | Grant / award · A | +5,100 | — | — | 13,959 |
| Wan Mark A | Director | Jun 22 | Grant / award · A | +5,100 | — | — | 13,959 |
| Adams Adrian | Director | Jun 22 | Grant / award · A | +5,100 | — | — | 22,709 |
| Church Jill Marie | Director | Jun 22 | Grant / award · A | +5,100 | — | — | 13,647 |
| Todisco Joseph | Director | Jun 22 | Grant / award · A | +5,100 | — | — | 11,497 |
| Bozilenko Marina | Director | Jun 22 | Grant / award · A | +5,100 | — | — | 14,147 |
| Jain Abhinav | Director | Jun 22 | Grant / award · A | +5,100 | — | — | 12,412 |
| Aslam Shakil | Chief Medical Officer | May 20 | Withheld — tax / exercise cost · F | −4,518 | $0.82 | −$3.72K | 76,542 |
| Dasu Badri N | Chief Engineering Officer | Apr 02 | Withheld — tax / exercise cost · F | −2,444 | $0.72 | −$1.77K | 71,440 |
| Asadorian Raffi | Chief Financial Officer | Apr 02 | Withheld — tax / exercise cost · F | −2,444 | $0.72 | −$1.77K | 85,879 |
| Angotti Vincent J. | CHIEF EXECUTIVE OFFICER | Apr 02 | Withheld — tax / exercise cost · F | −9,938 | $0.72 | −$7.18K | 790,767 |
| Aslam Shakil | Chief Medical Officer | Apr 02 | Withheld — tax / exercise cost · F | −2,118 | $0.72 | −$1.53K | 81,060 |
| Angotti Vincent J. | CHIEF EXECUTIVE OFFICER | Mar 13 | Open-market buy · P | +213,310 | $0.59 | +$125K | 800,705 |
| Dasu Badri N | Chief Engineering Officer | Feb 14 | Withheld — tax / exercise cost · F | −2,346 | $0.79 | −$1.86K | 73,884 |
| Asadorian Raffi | Chief Financial Officer | Feb 14 | Withheld — tax / exercise cost · F | −2,933 | $0.79 | −$2.33K | 88,323 |
| Angotti Vincent J. | CHIEF EXECUTIVE OFFICER | Feb 14 | Withheld — tax / exercise cost · F | −9,559 | $0.79 | −$7.58K | 577,395 |
| Dasu Badri N | Chief Engineering Officer | Feb 12 | Open-market buy · P | +35,000 | $0.81 | +$28.4K | 76,230 |
| Asadorian Raffi | Chief Financial Officer | Feb 12 | Open-market buy · P | +45,000 | $0.81 | +$36.6K | 91,256 |
| Angotti Vincent J. | CHIEF EXECUTIVE OFFICER | Feb 12 | Open-market buy · P | +105,364 | $0.81 | +$85.6K | 586,954 |
| Aslam Shakil | Chief Medical Officer | Feb 12 | Open-market buy · P | +35,000 | $0.81 | +$28.4K | 83,178 |
Loading...
